EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Optimizing Cancer Treatment Through Gut Microbiome Modulation

Kyuri Kim iD, Mingyu Lee, Yoojin Shin, Yoonji Lee, Tae-Jung Kim iD

Cancers · 07.04.2025 · 17 (7) · 1252

DOI: 10.3390/cancers17071252 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.04.2025. Verfasst von Kyuri Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Ewha Womans University, 25 Magokdong-ro 2-gil, Gangseo-gu, Seoul 03760, Republic of Korea. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, the Korean government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome plays a pivotal role in modulating cancer therapies, including immunotherapy and chemotherapy. Emerging evidence demonstrates its influence on treatment efficacy, immune response, and resistance mechanisms. Specific microbial taxa enhance immune checkpoint inhibitor efficacy, while dysbiosis can contribute to adverse outcomes. Chemotherapy effectiveness is also influenced by microbiome composition, with engineered probiotics and prebiotics offering promising strategies to enhance drug delivery and reduce toxicity. Moreover, microbial metabolites, such as short-chain fatty acids, and engineered microbial systems have shown potential to improve therapeutic responses. These findings underscore the importance of personalized microbiome-based approaches in optimizing cancer treatments.

Schlagwörter

Stichwörter der Autor:innen

cancerchemotherapyimmunotherapymicrobial metabolitemicrobiomeprebioticsprobiotics

Autor:innen und Institutionen

  • College of Medicine, Ewha Womans University, 25 Magokdong-ro 2-gil, Gangseo-gu, Seoul 03760, Republic of Korea.
  • College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
  • Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 10, 63-ro, Yeongdeungpo-gu, Seoul 07345, Republic of Korea.

ORCID-Profile: Kyuri Kim, Tae-Jung Kim

Förderung

  • National Research Foundation of Korea
  • the Korean government (MSIT)

Zitieren

APA

Kim, K., Lee, M., Shin, Y., Lee, Y., & Kim, T. J. (2025). Optimizing Cancer Treatment Through Gut Microbiome Modulation. Cancers, 17(7), 1252. https://doi.org/10.3390/cancers17071252

Vancouver

Kim K, Lee M, Shin Y, Lee Y, Kim TJ. Optimizing Cancer Treatment Through Gut Microbiome Modulation. Cancers. 2025;17(7):1252. doi:10.3390/cancers17071252

BibTeX
@article{Kim2025,
  author = {Kim, Kyuri and Lee, Mingyu and Shin, Yoojin and Lee, Yoonji and Kim, Tae-Jung},
  title = {Optimizing Cancer Treatment Through Gut Microbiome Modulation},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {1252},
  doi = {10.3390/cancers17071252}
}
Kostenlos starten →